GH:NASDAQ
Guardant Health Inc
168,26 $
arrow_upward
+1,63%(+2,70) 1D
9 հոկ, 11:15:15 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
166,03 $
High
170,81 $
Low
166,03 $
Mkt. cap
22,58 մլրդ
Avg. vol.
1,87 մլն
Volume
323,89 հզր
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
Open
166,03 $
High
170,81 $
Low
166,03 $
Mkt. cap
22,58 մլրդ
Avg. vol.
1,87 մլն
Volume
323,89 հզր
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Investing.com
·
18 ժամ առաջ
Guardant Health receives European approval for breast cancer test
Stock Titan
·
19 ժամ առաջ
A blood test in Europe can help identify who may benefit from AstraZeneca’s breast cancer drug
Yahoo Finance
·
19 ժամ առաջ
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
Simply Wall Street
·
2 օր առաջ
How Positive Melanoma Test Data Will Impact Guardant Health Stock
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteguardanthealth.com